ADAG Adagene Inc.
$4.02
Adagene Inc. (ADAG) is confirmed to report earnings on August 12, 2026, before the market open. The consensus earnings estimate is a loss of $0.15 per share.
Earnings Date
2nd Quarter, Jun 2026
Aug 12
Wednesday · Before Open
Earnings Whisper
-
vs ($0.15)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
-
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Adagene Inc.
Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene Inc. is based in SAN FRANCISCO, Calif.
Sector
Healthcare
Industry
Biotechnology